These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4927759)

  • 21. Paper chromatographic identification of catecholamines.
    Laasberg LH; Shimosato S
    J Appl Physiol; 1966 Nov; 21(6):1929-34. PubMed ID: 5929329
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 23. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 24. Some arylalkylamines in rabbit brain.
    Boulton AA; Juorio AV; Philips SR; Wu PH
    Brain Res; 1975 Oct; 96(1):212-6. PubMed ID: 1175003
    [No Abstract]   [Full Text] [Related]  

  • 25. L-dopa, dopamine, and hypomania.
    Murphy DL; Goodwin FK; Brodie HK; Bunney WE
    Am J Psychiatry; 1973 Jan; 130(1):79-82. PubMed ID: 4682751
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined clinical and metabolic study of the effects of alpha-methyldopa on hypertensive patients.
    Prescott LF; Buhs RP; Beattie JO; Speth OC; Trenner NR; Lasagna L
    Circulation; 1966 Aug; 34(2):308-21. PubMed ID: 5969361
    [No Abstract]   [Full Text] [Related]  

  • 27. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 28. Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat.
    Goldin BR; Peppercorn MA; Goldman P
    J Pharmacol Exp Ther; 1973 Jul; 186(1):160-6. PubMed ID: 4723308
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of scopolamine on the cerebral accumulation of 14 C-catecholamines from 14 C-tyrosine.
    Hitzemann RJ; Loh HH; Domino EF
    Pharmacology; 1972; 8(4):291-9. PubMed ID: 4657977
    [No Abstract]   [Full Text] [Related]  

  • 30. Demethylation of 3-O-methyldopa.
    Chalmers JP; Davies DS; Draffan GH; Reid JL; Thorgeirsson SS
    Br J Pharmacol; 1971 Oct; 43(2):455P-456P. PubMed ID: 5158231
    [No Abstract]   [Full Text] [Related]  

  • 31. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
    Rivera-Calimlim L
    Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A three solvent partition chromatographic technique for the estimation of acid metabolites of catecholamines. Urinary DOMA, DOPAC and HVA.
    Vahidi A; Siva Sankar DV
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):156-60. PubMed ID: 5524313
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopa, 3-O-methyldopa, and metabolites in urine during oral L-3-O-methyldopa therapy.
    Sharpless NS; Tyce GM; Muenter MD; Dinapoli RP
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):770-81. PubMed ID: 4426145
    [No Abstract]   [Full Text] [Related]  

  • 34. Formation of dopamine from 3-methoxytyrosine. Fact or artifact?
    Carlsson A; Waldeck B
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(4):441-6. PubMed ID: 4260264
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of methyldopa and related agents on pressor responses to tyramine in reserpine-pretreated rats and dogs.
    Torchiana ML; Wenger HC; Stavorski J; Ludden CT; Stone CA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):242-52. PubMed ID: 5932601
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat.
    Uretsky NJ
    J Pharmacol Exp Ther; 1974 May; 189(2):359-69. PubMed ID: 4829219
    [No Abstract]   [Full Text] [Related]  

  • 37. The 4-o-methyl metabolites of catecholamines. Homo-iso-vanillic acid in rat urine and brain; urinary iso-vanyl compounds after intraperitoneal administration of dopamine and of dopamine precursors and derivatives.
    Mathieu P; Charvet JC; Greffe J
    Biochem Pharmacol; 1975 Jan; 24(1):43-8. PubMed ID: 1122261
    [No Abstract]   [Full Text] [Related]  

  • 38. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
    Rubenson A
    J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
    [No Abstract]   [Full Text] [Related]  

  • 39. The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine.
    Porter CC; Totaro JA; Burcin A
    J Pharmacol Exp Ther; 1965 Oct; 150(1):17-22. PubMed ID: 5853698
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolism of 3-hydroxytyramine (dopamine) in human subjects.
    Goodall M; Alton H
    Biochem Pharmacol; 1968 Jun; 17(6):905-14. PubMed ID: 5661353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.